Harnessing Nature’s Insight: Design of Aspartyl Protease Inhibitors from Treatment of Drug-Resistant HIV to Alzheimer’s Disease

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTHarnessing Nature's Insight: Design of Aspartyl Protease Inhibitors from Treatment of Drug-Resistant HIV to Alzheimer's Disease†Arun K. Ghosh‡View Author Information Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, Indiana 47907†Adapted from a lecture presented at the Robert Scarborough Award Symposium, 236th National Meeting of the American Chemical Society, Philadelphia, PA, August 17−21, 2008; Abstract MEDI-211.‡ Contact information: phone, (765) 494-5323; fax, (765) 496-1612; e-mail, [email protected]Cite this: J. Med. Chem. 2009, 52, 8, 2163–2176Publication Date (Web):March 26, 2009Publication History Received16 January 2009Published online26 March 2009Published inissue 23 April 2009https://pubs.acs.org/doi/10.1021/jm900064chttps://doi.org/10.1021/jm900064creview-articleACS PublicationsCopyright © 2009 American Chemical SocietyRequest reuse permissionsArticle Views5277Altmetric-Citations41LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstract